ADAM17 and congestive heart failure: In contrast, pulmonary ADAM17 expression exhibited distinct pattern, where this enzyme was increased by ~2 fold (1.97 ± 0.39; P = .09) in compensated rats and declined by ~40% (0.6 ± 0.07; P < .01) in decompensated CHF subgroup (Figure 5C).